Skip to main content
EJNMMI Research

Table 5 Concordance analysis of cardiac findings between FLT and FDG-PET in subjects satisfying the HRS criteria for CS (N = 12)

From: FLT-PET for the assessment of systemic sarcoidosis including cardiac and CNS involvement: a prospective study with comparison to FDG-PET

 

Agreement†

Subjects with LV uptake

0.81 (95% CI 0.47 to 1.0)

Subjects with RV uptake

0.57 (95% CI 0.08 to 1.0)

# of LV segments involved

0.81 (95% CI 0.49 to 0.94)

# of segments in LAD territory

0.81 (95% CI 0.51 to 0.94)

# of segments in LCX territory

0.54 (95% CI 0.03 to 0.83)

# of segments in RCA territory

0.84 (95% CI 0.56 to 0.95)

Maximum LV SUV

0.22 (95% CI − 0.38 to 0.69)

Maximum RV SUV

0.36 (95% CI − 0.24 to 0.76)

Mean segmental SUV

 − 0.002 (95% CI − 0.58 to 0.57)

LV SUVTotal

0.20 (95% CI − 0.42 to 0.70)

  1. †Agreement between categorical and continuous variables was assessed using Cohen’s kappa and the intraclass correlation coefficient, respectively
Back to article page